Question 1

What is LOPJLB’s current signal on SLRX?

Accepted Answer

LOPJLB’s latest quantitative signal on Salarius Pharmaceuticals, Inc. (SLRX) is SELL in a RECOVERY regime. Signals are updated daily.

Question 2

What market regime is SLRX in?

Accepted Answer

Salarius Pharmaceuticals, Inc. (SLRX) is currently classified in the RECOVERY HMM market regime on LOPJLB.

Question 3

What does Salarius Pharmaceuticals, Inc. (SLRX) do?

Accepted Answer

Salarius Pharmaceuticals, Inc. is a clinical-stage biotechnology firm dedicated to advancing epigenetic-based cancer therapies. Its flagship investigational product, Seclidemstat (SP-2577), a small molecule inhibitor, is currently undergoing Phase I/II clinical evaluation. This compound is being developed to treat Ewing sarcoma and a range of advanced solid tumors. Another promising program inv…

Question 4

Where is Salarius Pharmaceuticals, Inc. based / listed?

Accepted Answer

Salarius Pharmaceuticals, Inc. is based in US, listed on NASDAQ.

Salarius Pharmaceuticals, Inc. (SLRX)

Key stats

Prediction markets

ANALYST & RATINGS

Company news